Table 2.

Characteristics of women with breast cancer, by year of diagnosis and age.

Variables	<45					45–74					75+
	2019		2020			2019		2020			2019		2020
	n	%	n	%	p-Value	n	%	n	%	p-Value	n	%	n	%	p-Value
Overall	63		56			377		423			130		110
Invasive	53	84.1	48	85.7	0.809	316	83.8	359	84.9	0.683	128	98.5	106	96.4	0.300
In situ	10	15.9	8	14.3		61	16.2	64	15.1		2	1.5	4	3.6
Only invasive
Morphology
ductal	45	84.9	44	91.7	0.535	259	82.0	285	79.4	0.046	91	71.1	83	78.3	0.107
lobular	3	5.7	2	4.2		51	16.1	54	15.0		23	18.0	9	8.5
other	5	9.4	2	4.2		6	1.9	20	5.6		14	10.9	14	13.2
pT
T1	25	47.2	16	33.3	0.225	211	66.8	244	68.0	0.885	47	36.7	33	31.1	0.189
T2	8	15.1	10	20.8		47	14.9	51	14.2		30	23.4	28	26.4
T3	2	3.8	0	0.0		7	2.2	9	2.5		4	3.1	3	2.8
T4	0	0.0	0	0.0		0	0.0	1	0.3		8	6.3	1	0.9
Unknown	18	34.0	22	45.8		51	16.1	54	15.0		39	30.5	41	38.7
N
N0	31	58.5	30	62.5	0.681	231	73.1	259	72.1	0.893	85	66.4	76	71.7	0.605
N+	22	41.5	18	37.5		81	25.6	94	26.2		37	28.9	27	25.5
Unknown	0	0.0	0	0.0		4	1.3	6	1.7		6	4.7	3	2.8
M
M0	51	96.2	43	89.6	0.178	310	98.1	349	97.2		123	96.1	102	96.2
M1	2	3.8	5	10.4		6	1.9	10	2.8		5	3.9	4	3.8
Stage
I	25	47.2	15	31.3	0.353	192	60.8	226	63.0	0.435	45	35.2	40	37.7	0.495
II	17	32.1	20	41.7		92	29.1	91	25.3		57	44.5	52	49.1
III	8	15.1	6	12.5		25	7.9	27	7.5		19	14.8	10	9.4
IV	2	3.8	5	10.4		6	1.9	10	2.8		5	3.9	4	3.8
Unknown	1	1.9	2	4.2		1	0.3	5	1.4		2	1.6	0	0.0
Grading
1	4	7.5	1	2.1	0.175	22	7.0	22	6.1	0.280	4	3.1	3	2.8	0.305
2	28	52.8	19	39.6		211	66.8	236	65.7		83	64.8	80	75.5
3	17	32.1	25	52.1		80	25.3	90	25.1		33	25.8	20	18.9
Unknown	4	7.5	3	6.3		3	0.9	11	3.1		8	6.3	3	2.8
Screening
Screen-detected						199	63.0	228	63.5	0.003
Interval cancers *						85	26.9	81	22.6
non attenders						27	8.5	24	6.7
not eligible						5	1.6	26	7.2
Total	53		48			316		359			128		106

* Interval cancers include all women with non-screen detected cancer and who had a negative screening test before cancer diagnosis, independently of the time elapsed since the negative test.